TABLE 3.
Follow-up outcomes.
Variables | Number or mean | Range or % |
Patients in follow-up | 310 | 90% |
Follow-up time, months | 42 ± 22 | 1–108 |
Major adverse events | ||
Chimney occlusion or stenosis | 6 | 1.7% |
Stent-graft migration | 2 | 0.6% |
Distal intimal tear | 3 | 0.9% |
Major stroke | 9 | 2.6% |
Spinal cord ischemia | 1 | 0.3% |
RAAD | 4 | 1.2% |
Aortic rupture | 4 | 1.2% |
Re-intervention | 14 | 4.1% |
Surgery for RAAD | 3 | 0.9% |
TEVAR for distal tear | 3 | 0.9% |
For type IA endoleak | 3 | 0.9% |
For type II endoleak | 2 | 0.6% |
For compressed chimney stents | 2 | 0.6% |
For chimney stent migration | 1 | 0.3% |
Aorta-related mortality | 4 | 1.2% |
All-cause mortality | 23 | 6.7% |
RAAD, retrograde type A aortic dissection.